HCID 59519011, compound → HCID 59518984, compound
Reaction equation
[C:1]([O:5][C:6]([N:8]1[CH2:14][CH2:13][CH2:12][N:11]([C:15]2[CH:20]=[CH:19][C:18]([N+:21]([O-])=O)=[C:17]([C:24](=[O:33])[NH:25][CH2:26][C:27](=[O:32])[NH:28][CH:29]([CH3:31])[CH3:30])[CH:16]=2)[CH2:10][CH:9]1[CH3:34])=[O:7])([CH3:4])([CH3:3])[CH3:2]>CO.[Pd]>[C:1]([O:5][C:6]([N:8]1[CH2:14][CH2:13][CH2:12][N:11]([C:15]2[CH:20]=[CH:19][C:18]([NH2:21])=[C:17]([C:24](=[O:33])[NH:25][CH2:26][C:27](=[O:32])[NH:28][CH:29]([CH3:30])[CH3:31])[CH:16]=2)[CH2:10][CH:9]1[CH3:34])=[O:7])([CH3:3])([CH3:2])[CH3:4]Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
4-{3-[(Isopropylcarbamoylmethyl)carbamoyl]-4-nitrophenyl}-2-methylperhydro-1,4-diazepine-1-carboxylic acid tert-butyl ester (100 mg, 0.209 mmol) and 10% Pd/C (10 mg, 0.209 mmol) in MeOH (5 mL) was stirred under 4 bar H2 (g) at room temperature overnight. The mixture was filtered through a pad of celite and the solvent removed in vacuo to afford 4-{4-amino-3-[(isopropylcarbamoylmethyl)carbamoyl]phenyl}-2-methylperhydro-1,4-diazepine-1-carboxylic acid tert-butyl ester (INTERMEDIATE V.53) (94 mg, 0.210 mmol, 100%). This was used directly without purification.
Workup
- filtrationThe mixture was filtered through a pad of celite
- customthe solvent removed in vacuo
Sources & evidence
- ORD record
- ord-fa00daa2e509490b9ffce313929665c2
- Source dataset
- uspto-grants-2010_10
- Patent number
- US07820649B2
Reaction notes
Loading…